LBB Specialities LLC (LBBS; Norwalk, Connecticut) has announced a new partnership with SE Tylose USA (Plaquemine, Louisiana), for cellulose excipients in the pharma excipients and nutra ingredients markets. Effective Nov. 1, 2024, this collaboration will span LBBS' life sciences and food and nutrition verticals across the US, Canada, the Caribbean and Central America. SE Tylose USA is an affiliate of Shin-Etsu Chemical Co, as per Chemweek.
The partnership will encompass Shin-Etsu SE Tylose’s cellulose excipients, which are used in pharmaceutical and nutraceutical applications for their functionalities such as binding, thickening and controlled release properties.
“This partnership with SE Tylose complements our existing portfolio of active pharmaceutical ingredients (APIs) and value-added excipients for solid dose applications in pharmaceuticals,” said Seth Burns, senior VP of Life Sciences at LBBS.
Shin-Etsu SE Tylose, based in Wiesbaden, Germany, produces approximately 65,000 metric tons per year of cellulose ether. Its products are used in construction materials to pharmaceuticals and food ingredients. LBBS brings a regulatory team to support customer development and dedicated technical marketing resources for product formulation and trends consultation, added LBBS.
Shin-Etsu Chemical will invest about 83 billion yen (USD545 million) to build a plant in Gunma Prefecture, Japan, to produce semiconductor materials. It is the first time in 56 years that Shin-Etsu Chemical has built a new production base in Japan.
mrchub.com